SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	401.10M
Revenue (ttm)	664.50M
Net Income (ttm)	14.37M
Shares Out	8.22M
EPS (ttm)	1.75
PE Ratio	27.96
Forward PE	n/a
Dividend	1.03 (2.10%)
Ex-Dividend Date	n/a

Volume	32
Average Volume	673
Open	48.80
Previous Close	48.80
Day's Range	48.80 - 48.80
52-Week Range	25.90 - 58.00
Beta	0.47
RSI	48.83
Earnings Date	Mar 6, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1969
• Employees: 618
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2024, SALUS, Ljubljana, d. d.'s revenue was 648.83 million, an increase of 8.24% compared to the previous year's 599.44 million. Earnings were 12.85 million, an increase of 25.14%.